Researchers have found a way to program immune cells to attack glioblastoma and treat the inflammation of multiple sclerosis in mice.
Device volumes to hold up against threat of Wegovy, other GLP-1 drugs: analysts
Dive Brief: The emergence of diabetes and obesity drugs that improve cardiovascular outcomes will have little impact on demand for medical devices, according to analysts.
August 9, 2023